Davide Ciardiello

Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With <i>RAS</i> Wild-type Metastatic Colorectal Cancer

Erika Martinelli, Giulia Martini, Vincenzo Famiglietti et al. · JAMA Oncology · 2021 · 174 citations · Full text

Primary and Acquired Resistance of Colorectal Cancer Cells to Anti-EGFR Antibodies Converge on MEK/ERK Pathway Activation and Can Be Overcome by Combined MEK/EGFR Inhibition

Teresa Troiani, Stefania Napolitano, Donata Vitagliano et al. · Clinical Cancer Research · 2014 · 100 citations

Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines

Pietro Paolo Vitiello, Claudia Cardone, Giulia Martini et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 87 citations · Full text

EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer

Giulia Martini, Claudia Cardone, Pietro Paolo Vitiello et al. · Molecular Cancer Therapeutics · 2019 · 84 citations · Full text

AXL is an oncotarget in human colorectal cancer

Erika Martinelli, Giulia Martini, Claudia Cardone et al. · Oncotarget · 2015 · 64 citations · Full text

Tumor Biology, Oncogenic Agent, Medicine +11